چاپ مقاله ISI ارزان
پلان مشارکتی واگذاری جایگاه نویسنده در مجلات Q1 و Q2

Journals

• Scientific Report - IF: 3.8 - Q1
• Tissue and cell - IF: 2.7 - Q1
• Plos one - IF: 2.9 - Q1
• DNA Research - IF: 3.9 - Q1
• DNA and cell biology - IF: 2.6 - Q2
• Cancer medicine - IF: 2.9 - Q2
• Cancer biology and medicine - IF: 5.6 - Q1

Titles

1. Investigating the Molecular Mechanisms of Plant-Derived Compounds (e.g., Resveratrol, Curcumin, Quercetin) on Inflammatory Signaling Pathways Triggered by Immune System Hyperactivation
2. Comparative Effects of Different Plant-Based Prebiotics (e.g., Curcumin, Piperine) on Microbiome Composition and Mitigation of Gastrointestinal Complications in Animal Models or Small-Scale Clinical Trials
3. Systematic Screening of Unexplored Plant Extracts (e.g., Silibinin, Thymol) for the Most Potent Neuroprotective Effects Against Taxane-Induced Toxicity
4. Utilization of Specific Plant Secondary Metabolites (e.g., Resveratrol, Quercetin) for the Prevention or Treatment of Taxane-Induced Neuropathy (Paclitaxel, Docetaxel)
5. Application of Nano-Carrier Formulations Containing Plant Compounds (e.g., Curcumin, Selenium Nanoparticles) for Targeted Delivery to Protect Cardiac Tissue Against Doxorubicin-Induced Cardiotoxicity
6. Design, Synthesis, and Evaluation of Lipid or Polymeric Nanoparticles Loaded with Plant Extracts (e.g., Silibinin, Piperine) to Mitigate Doxorubicin-Induced Cardiotoxicity in Animal Models
7. Investigating the Role of Plant-Derived Adaptogens (e.g., Resveratrol, Thymol) in Modulating Psychophysiological Stress Responses Induced by Immunotherapy in Renal and Bladder Cancer
8. Evaluation of Plant-Derived Adaptogen Supplements (e.g., Curcumin, Quercetin) on Quality of Life, Fatigue, and Inflammatory Biomarkers in Patients Undergoing Immunotherapy
9. Effects of Engineered Plant Extracts on Inhibiting Specific Signaling Pathways to Reduce Adverse Effects of Aromatase Inhibitors in Advanced Prostate Cancer
10. Modulation of the Nrf2 Pathway by Plant Compounds (e.g., Resveratrol, Curcumin) for Protection of Healthy Kidney Tissue During Cisplatin Treatment
11. Evaluation of Plant Compounds (e.g., Quercetin, Silibinin) on Reducing Doxorubicin-Induced Cardiotoxicity in iPSC-Derived Cardiomyocytes (iPSC-CMs)
12. Investigation of Plant Compounds (e.g., Allicin, Piperine) in Modulating Autophagy as a Mechanism to Reduce Drug Resistance in Tamoxifen-Resistant Cell Lines (MCF-7/TAMR)
13. Screening of Plant Extracts (e.g., Thymol, Curcumin) for Protection of Bladder Epithelial Cells (HCV-29 Cell Line) Against Cyclophosphamide-Induced Cystitis
14. Investigation of Plant-Derived Adaptogen Extracts (e.g., Resveratrol, Quercetin) Interference with Androgen Receptor (AR) Signaling Pathways in Enzalutamide-Sensitive and Resistant Prostate Cancer Cell Models
15. Evaluation of Renal Protective Effects of Plant Extracts (e.g., Silibinin, Selenium Nanoparticles) on Cisplatin-Induced Toxicity in Human Renal Tubular Epithelial Cells (HK-2 Cell Line)